Latent View Analytics Limited — Capital/Financing Update 2026

Apr 1, 2026

April 02, 2026

==> picture [524 x 47] intentionally omitted <==

==> picture [524 x 48] intentionally omitted <==

BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Dalal Street, Mumbai-400 001. Bandra Kurla Complex Bandra East, Scrip Code: 543398 Mumbai 400 051 Scrip Symbol: LATENTVIEW

Dear Sir/Madam,

Sub: Disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015– Strategic Investment by Material Wholly Owned Subsidiary.

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (hereinafter referred to as ‘Listing Regulations’), we wish to inform that M/s. LatentView Analytics Corporation (Incorporated in New Jersey), a Material & Wholly Owned Subsidiary of the Company has executed a Simple Agreement for Future Equity Notes (SAFE Notes) on April 01, 2026 for a strategic investment of USD 3,000,000 (Three Million Dollars) in M/s. Healtheon AI INC. (a Delaware Corporation) (‘Target Entity’), specialized in Agentic-AI framework for Revenue Cycle Management (‘RCM’) services for healthcare providers in the US.

The detailed disclosure pursuant to Regulation 30(6) of the Listing Regulations read with the SEBI Circular SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, is enclosed herewith as ‘ Annexure – I ’.

. This announcement is also available on the website of the company i.e., https://www.latentview.com/ This is for your information and records.

Thanking you,

For Latent View Analytics Limited

PARTHASAR Digitally signed by PARTHASARATHY ATHY SRINIVASAN SRINIVASAN Date: 2026.04.02 00:22:03 +05'30'

P. Srinivasan

Company Secretary and Compliance Officer

==> picture [487 x 107] intentionally omitted <==

Annexure – I

==> picture [66 x 66] intentionally omitted <==

Details required under the Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated 13 July 2023

	S.No.		Particulars		Details
	a)		Name of the target entity & brief details about the Company		Name: Healtheon AI INC, Brief Details –A Delaware Corporation incorporated on March 20, 2026. Financial highlights of FY 25 -Not applicable
	b)		Whether the acquisition would fall within related party transaction(s) and whether the promoter/ promoter group/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is done at arm’s length		The Acquisition does not fall within related party transactions. Further, the promoters are not interested in the Target entity.
	c)		Industry to which the entity being acquired belongs		Revenue Cycle Management for healthcare service providers
	d)		Objects and impact of acquisition (including but not limited to, disclosure of reasons for acquisition of target entity, if its business is outside the main		To secure a cornerstone stake in a high- moat, AI-agentic framework targeting the Revenue Cycle Management sector.

==> picture [66 x 66] intentionally omitted <==

==> picture [426 x 635] intentionally omitted <==

----- Start of picture text -----

line of business of the listed
entity)
Brief details of any
governmental or regulatory
e) Not Applicable
approvals required for the
acquisition
Whether the transaction will be
f) No
in tranches
The SAFE investment of USD 3,000,000 is
scheduled to be completed on or before
April 07, 2026.
Vide the SAFE Agreement,
M/s. LatentView Analytics Corporation
Indicative time period for
g) (Material & Wholly owned subsidiary) is
completion of the acquisition;
eligible to convert their investment into
SAFE Preferred Stock of the Target Entity
on the happening of certain events such
as future equity financing by the Target
Entity and other triggers as may be
agreed in the SAFE agreement.
Consideration – whether cash
consideration or share swap or
h) All cash consideration
any other form and details of
the same
Cost of SAFE Investment: USD 3,000,000
Cost of acquisition and/or the
i) price at which the shares are
Price of Acquisition : Not applicable for
acquired SAFE Investment.
----- End of picture text -----

==> picture [66 x 66] intentionally omitted <==

			The cost of acquisition of SAFE Preferred Stock will be determined on the happening of certain events such as future equity financing by the Target Entity and other triggers as may be agreed in the SAFE agreement.	The cost of acquisition of SAFE Preferred Stock will be determined on the happening of certain events such as future equity financing by the Target Entity and other triggers as may be agreed in the SAFE agreement.	The cost of acquisition of SAFE Preferred Stock will be determined on the happening of certain events such as future equity financing by the Target Entity and other triggers as may be agreed in the SAFE agreement.
j)	Existing percentage of share held by the acquirer		Nil
k)	Percentage of shareholding / control acquired and / or number of shares acquired		As the investment is structured via SAFE, there is no immediate acquisition of shares or voting control.
l)	Brief background about the entity acquired in terms of products/line of business acquired, date of incorporation, history of last 3 years turnover, country in which the acquired entity has presence and any other significant information (in brief)		Products/line of business of the Target Company	Revenue Cycle Management for healthcare service providers
			Date of Incorporation	March 20, 2026
			Global presence	US
			Last 3 years Turnover	Not applicable since the Target Company was recently incorporated.

For Latent View Analytics Limited

PARTHASAR Digitally signed by PARTHASARATHY ATHY SRINIVASAN Date: 2026.04.02 SRINIVASAN 00:23:01 +05'30'

P. Srinivasan

Company Secretary and Compliance Officer